Researchers optimize a route for two-step synthesis of antiviral plant protectant

Plant viruses are of great variety and harm. Virus disease pandemics and epidemics were estimated to have a global economic impact in the tens of billions of dollars. At present, there are not many effective and satisfactory varieties of anti-plant virus agents in practical use, especially few therapeutic agents.

In the face of the harm of virus to agricultural production, it is necessary to develop environmentally friendly anti-plant virus drugs. It is increasingly important and growing research focus to find drug candidates from natural products. Natural products possess many of the properties that can make them useful drug candidates, including structural diversity, specificity and novel modes of action. However, natural products also have some disadvantages, such as limited compound availability, high structural complexity and poor drug-likeness. Therefore, pesticide creation based on natural products has become an important direction of green pesticide creation through biological rational design on the basis of exploring new active lead or molecule with new action target.

Tryptophan is one of the essential amino acids and the biosynthetic precursor of many alkaloids. Prof. Qingmin Wang and Dr. Hongjian Song from Nankai University previously found that tryptophan, the biosynthesis precursor of Peganum harmala alkaloids, and its derivatives have anti-TMV activity both in vitro and in vivo. Further exploration of this led to the identification of NK0238 as a highly effective agent for the prevention and control of diseases caused by plant viruses, but the existing routes are unsuitable for its large-scale synthesis.

They optimized a route for two-step synthesis of this virucide candidate. The optimized route provides a solid foundation for its large-scale synthesis and subsequent efficacy and toxicity studies. Field experiment results showed that it had good effect on multiple plant viruses. The oral toxicity of rats was mild, which had no effect on the safety of birds, fish bees. This study entitled "Route development, antiviral studies, field evaluation and toxicity of an antiviral plant protectant NK0238" is published on the Journal of Frontiers of Agricultural Science and Engineering in 2022.

In this study, a two-step synthetic route for the antiviral plant protectant, NK0238, was developed. By this route, NK0238 can be obtained in 94% yield and nearly 97% HPLC purity. Compared with the previously reported routes, this route has the advantages of high atom economy, high yield and operational simplicity. In addition, it can be used for the preparation of more than 40 g of NK0238 in a single batch.

After completing the process optimization, an in-depth study of antiviral activity in greenhouse and field experiments and toxicity tests were conducted. NK0238 exhibited a broad antiviral spectrum, in field experiments, the activities of NK0238 against TMV, pepper virus, panax notoginseng virus Y, gladiolus mosaic virus, banana bunchy top virus were equal to or higher than amino-oligosaccharins and moroxydine hydrochloride-copper acetate. The results of ecotoxicological testing showed that the compound was not harmful to birds, fish, bees and silkworms, its excellent activity and safety make NK0238 a promising drug candidate for further development.

Source:
Journal reference:

Xu, W., et al. (2022) Route development, antiviral studies, field evaluation and toxicity of an antiviral plant protectant NK0238. Frontiers of Agricultural Science and Engineering. doi.org/10.15302/J-FASE-2021390.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Research Highlights Brain Connectivity as Key Factor in Cognitive Aging